0001250853-13-000002.txt : 20130107 0001250853-13-000002.hdr.sgml : 20130107 20130107173329 ACCESSION NUMBER: 0001250853-13-000002 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121231 FILED AS OF DATE: 20130107 DATE AS OF CHANGE: 20130107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEVITT DANIEL J CENTRAL INDEX KEY: 0001278711 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-15327 FILM NUMBER: 13516147 MAIL ADDRESS: STREET 1: C/O DYNAVAX TECHNOLOGIES CORP STREET 2: 2929 SEVENTH ST STE 100 CITY: BERKELEY STATE: CA ZIP: 94710 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYTRX CORP CENTRAL INDEX KEY: 0000799698 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 581642750 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11726 SAN VICENTE BOULEVARD STREET 2: SUITE 650 CITY: LOS ANGELES STATE: CA ZIP: 90049 BUSINESS PHONE: 310-826-5648 MAIL ADDRESS: STREET 1: 11726 SAN VICENTE BOULEVARD STREET 2: SUITE 650 CITY: LOS ANGELES STATE: CA ZIP: 90049 4/A 1 primary_doc.xml PRIMARY DOCUMENT X0306 4/A 2012-12-31 2013-01-02 0 0000799698 CYTRX CORP CYTR 0001278711 LEVITT DANIEL J 11726 SAN VICENTE BLVD., SUITE 650 LOS ANGELES CA 90049 0 1 0 0 EVP & Chief Medical Officer Common Stock 2012-12-31 4 A 0 100000 0 A 114286 D Reflects reduction in shares owned due to 1-for-7 reverse stock split of the Issuer's common stock in May 2012. /s/ Daniel J. Levitt 2013-01-05